Meet our CMO’s
Learn more about the Chief Medical Officers at Kent Imaging and their critical role in the company’s mission - improving outcomes and reducing complications in as many patients as possible.
Dr. Jeffrey Niezgoda
CMO Wound Care and Limb Preservation
Dr. Jeffrey Alan Niezgoda, MD, FACHM, MAPWCA, CHWS, is Kent Imaging’s Chief Medical Officer of wound care and limb preservation. He is the founder and President Emeritus of AZH Wound & Hyperbaric Medicine and the President & CMO of WebCME, an international educational company providing wound care and hyperbaric education. He is the President of the American Professional Wound Care Association and Past-President of the American College of Hyperbaric Medicine. A leader in his field, he is dedicated to excellence in wound, vascular, and regenerative clinical services.
Dr. Niezgoda is also the host of Kent Imaging’s NIRS Clinical Connection, a series of educational-based live webinars that takes audiences through clinical scenarios and image interpretation with Kent Imaging’s near-infrared spectroscopy device, SnapshotNIR.
These exclusive 30-minute presentations feature cases from his wound care practice as well as featured industry professionals sharing insights into the diagnostic-driven applications of NIRS in wound care. From diabetic foot wounds, venous ulcers, and hyperbaric oxygen therapy to skin substitutes, expert clinicians discuss the application of the technology and how they are improving outcomes for their patients and streamlining clinical efficiencies.
Dr. Niezgoda possesses a strong passion for bringing technology from the research bench to the clinical bedside where it can have a real contribution towards reducing complications and improving outcomes for patients. He is responsible for providing medical and clinical leadership for Kent’s wound care and limb preservation product strategy and clinical integration.
“Near-infrared spectroscopy imaging allows immediate and direct visualization of tissue oxygenation which truly enhances medical decision-making and will provide improved patient outcomes. The Kent team is comprised of talented and dedicated individuals working together to achieve excellence. I am thrilled to be part of this great organization.”
Dr. GLYN JONES
CMO Reconstructive Surgery
Dr. Glyn Jones, MD, FACS is dedicated to excellence in reconstructive and cosmetic surgery as a member of the American Society of Plastic Surgeons & American Association of Plastic Surgeons. Dr. Jones was a full-time faculty member and an Associate Professor of Plastic Surgery at Emory University for fifteen years, serving as the Department of Plastic Surgery Interim Chair, and was a recipient of the ‘Teacher of the Year’ award. He was then a Professor at the University of Illinois College of Medicine at Peoria (UICOMP) for 15 years while concurrently running a private practice. His primary focus as a surgeon has been on breast reconstruction for cancer, cosmetic surgery, and the management of complex wounds. An early adopter and supporter of Kent’s flagship product, SnapshotNIR, Dr. Jones has been using the near-infrared spectroscopy imaging device for 5 years.
In addition to lecturing extensively about breast reconstruction and plastic surgery, Dr. Jones has also authored and edited numerous book chapters on these topics. He is the author/editor of the recently published Bostwick’s Plastic & Reconstructive Breast Surgery, 3rd Edition, which is recognized as the definitive breast surgery reference for surgeons around the world. He also co-authored Reconstructive Surgery: Anatomy, Techniques and Clinical Application, with Michael Zenn.
As a pioneer in the clinical application of tissue assessment with SPY fluorescence imaging technology, Dr. Jones now brings his vast clinical and scientific experience to the Kent team to advance surgical imaging and patient care.
Dr. Jones will be responsible for providing medical and clinical leadership for Kent’s plastic and reconstructive surgery product strategy and clinical integration. An internationally recognized plastic surgeon who has experienced the gambit of procedures in his field, his passion for reducing complications in all patients, and his insights on optimizing the use of SnapshotNIR for acute wounds in surgery will be an incredible asset to Kent Imaging.
“The Snapshot technology adds a defined endpoint that we as surgeons can understand and act on. Using the StO2 readings as a surrogate for blood flow into the tissue, Snapshot helps me more accurately assess the viability of mastectomy skin flaps intraoperatively without the use of dyes or injectables.”